The Valvular Interventions Center

Filter Your Results

 

News

 

Off-Label Use of TAVR Evaluated in TVT Registry

June 26, 2017 -- An investigation of trends and outcomes of off-label use of transcatheter aortic valve replacement (TAVR) procedures found that approximately one in 10 patien…

Real-World Data Presented for BioTrace Medical's Tempo Lead in TAVR Procedures

June 19, 2017 -- BioTrace Medical, Inc. announced that data on the company’s Tempo temporary pacing lead were presented at TVT 2017, the Transcatheter Valve Therapies c…

Study Evaluates Changes in Exercise Capacity After TAVR

June 19, 2017 -- A study published online ahead of print by Omar Abdul-Jawad Altisent, MD, et al in Circulation investigated the predictors of and association with clinical ou…

Venus Medtech Acquires InterValve

June 14, 2017 -- Venus Medtech Inc. announced that it has purchased InterValve, Inc. Beginning in June 2017, Venus Medtech will be responsible for the global production and sa…

German Study Compares Transfemoral TAVR With Boston Scientific's Lotus Device Versus Edwards' Sapien 3

June 12, 2017 -- Principal investigator Jochen Wöhrle, MD, at the University of Ulm in Ulm, Germany, led a single-center investigation comparing the 30-day, 12-month, and…

United States Enrollment Begins in Early Feasibility Study of HLT's TAVR System

June 6, 2017 -- HLT, Inc. announced that the first United States procedures were performed in the early feasibility RADIANT clinical study. The RADIANT trial seeks to assess t…

FDA Clears Claret Medical's Sentinel Cerebral Protection System for TAVR Procedures

June 5, 2017 -- Claret Medical, Inc. announced that it has received clearance from the US Food and Drug Administration (FDA) for the Sentinel cerebral protection system (CPS…

FDA Approves Expanded Indication for Use of Edwards Sapien 3 for Valve-in-Valve Treatment in High-Risk Patients

June 5, 2017 -- Edwards Lifesciences Corporation announced that it has received US Food and Drug Administration (FDA) approval for aortic and mitral valve-in-valve procedures …

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.